SELLAS LIFE SCIENCES GROUP I's ticker is SLS and the CUSIP is 81642T209. A total of 28 filers reported holding SELLAS LIFE SCIENCES GROUP I in Q1 2022. The put-call ratio across all filers is 0.71 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $386,510 | +30.9% | 235,603 | +25.3% | 0.00% | – |
| Q2 2023 | $295,263 | +9.8% | 188,066 | 0.0% | 0.00% | – |
| Q1 2023 | $268,934 | +60607.4% | 188,066 | 0.0% | 0.00% | – |
| Q4 2022 | $443 | -99.8% | 188,066 | +30.0% | 0.00% | – |
| Q3 2022 | $292,000 | -9.3% | 144,719 | 0.0% | 0.00% | – |
| Q2 2022 | $322,000 | -64.8% | 144,719 | +5.7% | 0.00% | – |
| Q1 2022 | $914,000 | +23.7% | 136,896 | +2.3% | 0.00% | – |
| Q4 2021 | $739,000 | -39.7% | 133,801 | 0.0% | 0.00% | – |
| Q3 2021 | $1,225,000 | +9.0% | 133,801 | +32.0% | 0.00% | – |
| Q2 2021 | $1,124,000 | +38.8% | 101,337 | +6.8% | 0.00% | – |
| Q1 2021 | $810,000 | +307.0% | 94,907 | +175.8% | 0.00% | – |
| Q4 2020 | $199,000 | +23.6% | 34,415 | -43.5% | 0.00% | – |
| Q3 2020 | $161,000 | -9.0% | 60,914 | +0.5% | 0.00% | – |
| Q2 2020 | $177,000 | +94.5% | 60,614 | +14.8% | 0.00% | – |
| Q1 2020 | $91,000 | -79.5% | 52,787 | -49.1% | 0.00% | – |
| Q4 2019 | $444,000 | – | 103,702 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alyeska Investment Group, L.P. | 1,250,000 | $1,787,500 | 0.02% |
| Alyeska Investment Group, L.P. | 1,000,000 | $1,430,000 | 0.01% |
| Opus Capital Group, LLC | 25,000 | $36 | 0.01% |
| Equitable Holdings, Inc. | 130,000 | $185,900 | 0.00% |
| VANGUARD GROUP INC | 896,912 | $1,282,584 | 0.00% |
| WealthPLAN Partners, LLC | 1 | $1 | 0.00% |
| OSAIC HOLDINGS, INC. | 1,660 | $2,373 | 0.00% |
| DIMENSIONAL FUND ADVISORS LP | 31,304 | $44,765 | 0.00% |
| WELLS FARGO & COMPANY/MN | 16,142 | $23,083 | 0.00% |
| NORTHERN TRUST CORP | 30,018 | $42,926 | 0.00% |